Myeloma Rounds Durham
March 4, 2025
Format
Live, In-Person Event
*Pre-registration required
Live interactive continuing medical education activity for healthcare professionals in Chapel Hill, Charlotte, Durham, Raleigh, Winston-Salem, and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity in intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with myeloma.
Agenda
5:30 PM – Dinner and Networking
6:30 PM – Welcome and Overview of Program
Cindy Varga, MD
6:35 PM –Overview of LLS Resources, including the Clinical Trial Support Center
Christen Hawthorne, RN, BSN, BMT-CN
6:40 PM – Updates in Multiple Myeloma Clinical Research
Eben Lichtman, MD
6:55 PM – Case Presentation on Bispecifics in the Community and Discussion*
Sendhilnathan (Hari) Ramalingam, MD and Cindy Varga, MD
7:25 PM – Case Presentation on High-risk Smoldering Multiple Myeloma and Discussion*
Kimberly Burcher, MD and Cristiana Costa Chase, DO
7:55 PM – Case Presentation on Maintenance Therapy in Transplant Eligible and Discussion*
John Mckay, DO and Sean Ormond, MD
8:25 PM – Discussion and Wrap-up
All Faculty
8:35 PM – Conclusion
Cindy Varga, MD
*Additional discussants: Drs. Gasparetto, Kang, and Voorhees
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
- Engage patients and caregivers in clinical trials discussions on newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bi-specific antibodies
- Explain disparities and challenges in diagnosis and treatment of myeloma
- Apply evidence-based treatment strategies for optimal patient care
- Identify patient education and support resources
Advisory Group
Cindy Varga, MD (Chair)
Levine Cancer Institute
Atrium Health
Charlotte, NC
Cristiana Costa Chase, DO
Duke Blood Cancer Center
Duke University Medical Center
Durham, NC
Grace Elsey, PharmD, BCOP
Levine Cancer Institute
Atrium Health
Charlotte, NC
Eben Lichtman, MD
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
John Mckay, DO
Wake Forest Baptist
Atrium Health
Winston-Salem, NC
Faculty
Cindy Varga, MD (Chair)
Levine Cancer Institute
Atrium Health
Charlotte, NC
Kimberly Burcher, MD
Duke University Hospital
Durham, NC
Cristiana Costa Chase, DO
Duke Blood Cancer Center
Duke University Medical Center
Durham, NC
Christen Hawthorne, RN, BSN, BMT-CN
The Leukemia & Lymphoma Society
Rye Brook, NY
Eben Lichtman, MD
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
John Mckay, DO
Wake Forest Baptist
Atrium Health
Winston-Salem, NC
Sean Ormond, MD
Wake Forrest Baptist
Atrium Health
Winston-Salem, NC
Sendhilnathan (Hari) Ramalingam, MD
Duke Adult Blood and Marrow Transplant Clinic
Duke Cancer Center Raleigh
Durham, NC
Guest Discussants: Cristina Gasparetto, MD, Yubin Kang, MD, and Peter Voorhees, MD
Continuing Education Information
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc and The Leukemia & Lymphoma Society. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
Physician Associate
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-25-005-L01-P
For Pharmacists, Medical Learning Institute will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at ndane@mlieducation.org.
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
There is no commercial support associated with this activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.